Star Combo Pharma Limited (ASX:S66)
Australia · Delayed Price · Currency is AUD
0.2050
-0.0050 (-2.38%)
Mar 4, 2026, 9:59 AM AEST
Revenue by Segment
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | Jun '19 Jun 30, 2019 | Jun '18 Jun 30, 2018 | Jun '17 Jun 30, 2017 | Jun '16 Jun 30, 2016 |
|---|
| 25.83M | 23.36M | 20.75M | 16.21M | 12.54M | | | | | |
Star Combo Business Growth | 10.57% | 12.55% | 28.05% | 29.22% | -6.50% | | | | | |
| 1.99M | 2.66M | 3.95M | 6.67M | 14.18M | | | | | |
| -25.39% | -32.60% | -40.85% | -52.95% | -44.21% | | | | | |
| 27.81M | 26.02M | 24.70M | 22.88M | 26.72M | | | | | |
| 6.89% | 5.34% | 7.95% | -14.38% | -31.18% | | | | | |
Revenue by Geography
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | Jun '19 Jun 30, 2019 | Jun '18 Jun 30, 2018 | Jun '17 Jun 30, 2017 | Jun '16 Jun 30, 2016 |
|---|
| 26.37M | 24.81M | 20.48M | 16.67M | 16.73M | | | | | |
| 6.26% | 21.13% | 22.89% | -0.39% | -15.68% | | | | | |
| 1.45M | 1.21M | 4.22M | 6.21M | 9.99M | | | | | |
| 19.78% | -71.38% | -32.12% | -37.83% | -47.39% | | | | | |
| 27.81M | 26.02M | 24.70M | 22.88M | 26.72M | | | | | |
| 6.89% | 5.34% | 7.95% | -14.38% | -31.18% | | | | | |
Source: S&P Global Market Intelligence.